ESR1 and breast carcinoma: Triple-negative breast cancer (TNBC) is a heterogeneous collection of breast cancers lacking expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) amplification.